[Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
Berdichevskiĭ
M Ia
MIa
Karmirian
S A
SA
Geĭko
I I
II
Miroshnichenko
V E
VE
Parkhaeva
T N
TN
Popova
V G
VG
Timchenko
L V
LV
Filina
T V
TV
Aristova
L A
LA
D000208:Acute Disease; D001621:Betahistine / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000150:complications*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D017442:Histamine Agonists / Q000627:therapeutic use*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D020521:Stroke / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D013577:Syndrome; D016896:Treatment Outcome; D000159:Vestibulocochlear Nerve / Q000503:physiopathology
D017442:Histamine Agonists; D001621:Betahistine